Aurisco Pharmaceutical Co.,Ltd.

Informe acción SHSE:605116

Capitalización de mercado: CN¥9.0b

Aurisco PharmaceuticalLtd Crecimiento futuro

Future controles de criterios 5/6

Aurisco PharmaceuticalLtd is forecast to grow earnings and revenue by 27.4% and 23% per annum respectively. EPS is expected to grow by 27.4% per annum. Return on equity is forecast to be 19.6% in 3 years.

Información clave

27.4%

Tasa de crecimiento de los beneficios

27.4%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Pharmaceuticals19.3%
Tasa de crecimiento de los ingresos23.0%
Rentabilidad financiera futura19.6%
Cobertura de analistas

Low

Última actualización07 Oct 2024

Actualizaciones recientes sobre el crecimiento futuro

No hay actualizaciones

Recent updates

Is Aurisco PharmaceuticalLtd (SHSE:605116) A Risky Investment?

Sep 19
Is Aurisco PharmaceuticalLtd (SHSE:605116) A Risky Investment?

Is Now The Time To Put Aurisco PharmaceuticalLtd (SHSE:605116) On Your Watchlist?

Aug 14
Is Now The Time To Put Aurisco PharmaceuticalLtd (SHSE:605116) On Your Watchlist?

Investors Interested In Aurisco Pharmaceutical Co.,Ltd.'s (SHSE:605116) Earnings

Jun 28
Investors Interested In Aurisco Pharmaceutical Co.,Ltd.'s (SHSE:605116) Earnings

Aurisco PharmaceuticalLtd (SHSE:605116) Has A Pretty Healthy Balance Sheet

Jun 07
Aurisco PharmaceuticalLtd (SHSE:605116) Has A Pretty Healthy Balance Sheet

Investors Shouldn't Be Too Comfortable With Aurisco PharmaceuticalLtd's (SHSE:605116) Earnings

May 12
Investors Shouldn't Be Too Comfortable With Aurisco PharmaceuticalLtd's (SHSE:605116) Earnings

Here's Why We Think Aurisco PharmaceuticalLtd (SHSE:605116) Might Deserve Your Attention Today

Apr 22
Here's Why We Think Aurisco PharmaceuticalLtd (SHSE:605116) Might Deserve Your Attention Today

Previsiones de crecimiento de beneficios e ingresos

SHSE:605116 - Estimaciones futuras de los analistas y datos financieros pasados (CNY Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
12/31/20262,436638N/A5903
12/31/20252,033523N/A4723
12/31/20241,627395N/A3603
9/30/20241,428341-151398N/A
6/30/20241,441382-46405N/A
3/31/20241,296326-9395N/A
12/31/20231,26328980386N/A
9/30/20231,16225780367N/A
6/30/20231,0521909242N/A
3/31/20231,09121614221N/A
12/31/20221,008211-50166N/A
9/30/2022983222-122130N/A
6/30/2022911202-82185N/A
3/31/2022836177-52203N/A
12/31/2021803169-49202N/A
9/30/2021767151-15171N/A
6/30/2021741137-10172N/A
3/31/202172714034220N/A
12/31/202072115756214N/A
9/30/2020688206143255N/A
12/31/2019582186107180N/A
12/31/201857513716110N/A
12/31/201754445N/A118N/A
12/31/201659087N/A188N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: 605116's forecast earnings growth (27.4% per year) is above the savings rate (2.9%).

Beneficios vs. Mercado: 605116's earnings (27.4% per year) are forecast to grow faster than the CN market (25.8% per year).

Beneficios de alto crecimiento: 605116's earnings are expected to grow significantly over the next 3 years.

Ingresos vs. Mercado: 605116's revenue (23% per year) is forecast to grow faster than the CN market (14% per year).

Ingresos de alto crecimiento: 605116's revenue (23% per year) is forecast to grow faster than 20% per year.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: 605116's Return on Equity is forecast to be low in 3 years time (19.6%).

Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y